Press Releases
11 November 2019
SAN FRANCISCO, Nov. 11, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to a
Read more...DUBLIN, Nov. 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation and Fast Track Designation for ATM-AVI (aztreonam and avibactam), for the treatment of complicated intra-abdominal infections (cIAI), complicated urinary tract infections (cUTI)
Read more...DENVER, Nov. 11, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company") today announced the financial results for its third quarter of 2019.
Read more...11 November 2019
SANTA CLARA, Calif., Nov. 11, 2019 /PRNewswire/ -- Healthcare has evolved from a procedure volume-driven system to quality medicine and outcome-based system. If the focus is on improving the quality of outcomes and the health of a defined population, the cost per capita for delivering care will reduce. In line with this need, many physicians from different special
Read more...11 November 2019
HOUSTON, Nov. 11, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that it will host a conference call and webcast on Tuesd
Read more...CAMBRIDGE, Mass., Nov. 11, 2019 /PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to discover breakthrough medicines for patients, today announced the company will present new preclinical data showing its first-in-class selective and potent oral IRAK4 degraders demonstrate broad and robust in vitro and in
Read more...11 November 2019
JERSEY CITY, N.J., Nov. 11, 2019 /PRNewswire/ -- Lawsuit Settlement News announced today that they are preparing for an influx of JUUL electronic cigarette lawsuits, and have set up a helpline for plaintiffs seeking legal assistance. JUUL pods use a blend of liquids and flavorings which, when heated, becomes a vapor that can be inhaled, or "vaped."Lawsuits cl
Read more...11 November 2019
TOKYO, Nov. 11, 2019 /PRNewswire/ -- AI Medical Service Inc., one of the world's first real-time endoscopic artificial intelligence (AI) developers, today announced the Company has secured Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its AI programs that analyze endoscopy images for potential diagnosis of gastric cancer. Th
Read more...11 November 2019
TEL AVIV, Israel, Nov. 11, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended September 30, 2019 and provides a corporate update. Highlights and achievements during the third quarter 20
Read more...11 November 2019
HOLON, Israel, Nov. 11, 2019 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the third quarter ended September 30, 2019
Read more...
